Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-004628
Filing Date
2022-03-29
Accepted
2022-03-29 16:41:50
Documents
6
Effectiveness Date
2022-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220329xs8.htm S-8 83918
2 EX-5.1 tmb-20220329xex5d1.htm EX-5.1 14496
3 EX-23.2 tmb-20220329xex23d2.htm EX-23.2 3005
4 EX-23.3 tmb-20220329xex23d3.htm EX-23.3 3341
5 EX-FILING FEES tmb-20220329xexfilingfees.htm EX-FILING FEES 46352
6 GRAPHIC tmb-20220329xex5d1001.jpg GRAPHIC 1972
  Complete submission text file 0001558370-22-004628.txt   154973
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263948 | Film No.: 22781535
SIC: 2834 Pharmaceutical Preparations